FOLH1 and metastatic malignant neoplasm in the lymph nodes: Multiple studies have reported that the presence of lymph node metastasis does not impact the outcome (including PSA response or survival) after [177Lu]Lu-PSMA RLT [4, 24, 28, 30, 38, 39, 50, 55].